State Board Of Administration Of Florida Retirement System Seagen Inc. Transaction History

State Board Of Administration Of Florida Retirement System

$51.5 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$191.51 - $216.16 $789,021 - $890,579	-4,120 Reduced 2.63%	152,766 $32.4 Million
Q2 2023 Aug 11, 2023	BUY	$187.64 - $206.25 $836,311 - $919,256	4,457 Added 2.92%	156,886 $30.2 Million
Q1 2023 Jun 14, 2023	SELL	$127.59 - $203.08 $219,454 - $349,297	-1,720 Reduced 1.12%	152,429 $30.9 Million
Q1 2023 May 11, 2023	SELL	$127.59 - $203.08 $219,454 - $349,297	-1,720 Reduced 1.12%	152,429 $30.9 Million
Q4 2022 Jun 14, 2023	BUY	$117.37 - $139.17 $201,876 - $239,372	1,720 Added 1.13%	154,149 $19.8 Million
Q4 2022 Feb 07, 2023	SELL	$117.37 - $139.17 $190,139 - $225,455	-1,620 Reduced 1.04%	154,149 $19.8 Million
Q3 2022 Nov 08, 2022	SELL	$135.27 - $180.11 $218,461 - $290,877	-1,615 Reduced 1.03%	155,769 $21.3 Million
Q2 2022 Aug 05, 2022	SELL	$108.81 - $179.33 $1.63 Million - $2.68 Million	-14,950 Reduced 8.68%	157,384 $27.8 Million
Q1 2022 May 06, 2022	SELL	$119.61 - $157.85 $169,008 - $223,042	-1,413 Reduced 0.81%	172,334 $24.8 Million
Q4 2021 Feb 08, 2022	SELL	$142.57 - $190.86 $130,451 - $174,636	-915 Reduced 0.52%	173,747 $26.9 Million
Q3 2021 Nov 08, 2021	SELL	$142.45 - $169.82 $339,743 - $405,020	-2,385 Reduced 1.35%	174,662 $29.7 Million
Q2 2021 Aug 10, 2021	SELL	$135.08 - $161.1 $954,475 - $1.14 Million	-7,066 Reduced 3.84%	177,047 $28 Million
Q1 2021 May 10, 2021	SELL	$137.51 - $190.8 $545,364 - $756,712	-3,966 Reduced 2.11%	184,113 $25.6 Million
Q4 2020 Feb 08, 2021	BUY	$164.63 - $211.93 $31 Million - $39.9 Million	188,079 New	188,079 $32.9 Million

Others Institutions Holding SGEN

# of Institutions

Shares Held

1.26M

Call Options Held

23K

Put Options Held

55.2K

View Full List

About Seagen Inc.

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

More about SGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.

Account